Stock Replacement Astellas Access ProgramSM
The Astellas Access ProgramSM (AAP) provides stock replacement of injectable/infused medications that have been administered to eligible, uninsured patients who meet program qualifications. Evaluation of program criteria is patient-specific and retrospective to treatment.
Once the Astellas Access ProgramSM approves the patient for assistance, the provider will be notified. The number of product units administered to the patient will then be sent to the provider's office or hospital, at no cost to the healthcare provider. There is no limit to the amount of medications that may be approved for replacement for any given patient or institution when the request is evaluated as medically appropriate.
To apply to the Astellas Access ProgramSM on behalf of your patient, you must complete and submit a request via Astellas eService. The replacement request must be submitted within 180 days of the last date of service.
*The application must be submitted by the prescribing physician or an authorized employee at the treating facility.
